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Mixed-mode  chromatography  (MMC)  is  a  fast growing  area  in  recent  years,  thanks  to  the  new  gen-
eration  of  mixed-mode  stationary  phases  and better  understanding  of  multimode  interactions.  MMC
has  superior  applications  in  the  separation  of  compounds  that  are  not  retained  or not  well resolved
by  typical  reversed-phase  LC  methods,  especially  for polar  and  charged  molecules.  Due  to  the  multiple
retention  modes  that  a single  MMC  column  can  offer,  often  MMC  provides  additional  dimension  to a
separation  method  by  adjusting  the  mobile  phase  conditions.  Mixed-mode  media  is  also  an  effective  wayixed-mode chromatography
harmaceutics
iopharmaceutics
to  clean up  complex  sample  matrices  for  puriﬁcation  purposes  or for sensitive  detection  of  trace  amounts
of  analytes.  In this  article,  we  discuss  mixed-mode  stationary  phases  and  separation  mechanisms  and
review  recent  advances  in  pharmaceutical  and  biopharmaceutical  applications  including  the  analysis
and/or  puriﬁcation  of  counterions,  small  molecule  drugs,  impurities,  formulation  excipients,  peptides
and  proteins.
© 2016  The  Author(s).  Published  by Elsevier  B.V. This  is  an open  access  article  under  the CC  BY  license. Introduction
Mixed-mode chromatography (MMC)  or multimode chro-
atography is becoming increasingly popular in pharmaceutical
nd biopharmaceutical applications due to its unique selectiv-
ty and retention of a variety of compounds, especially polar
nd charged molecules [1–8]. MMC  is a chromatographic method
n which solutes interact with stationary phase through more
han one interaction mode or mechanism. MMC  has been used
s an alternative or complementary tool to traditional reversed-
hased (RP), ion exchange (IEX) and normal phase chromatography
NP). Unlike RP, NP and IEX chromatography, in which hydropho-
ic interaction, hydrophilic interaction and ionic interaction
espectively are the dominant interaction modes, mixed-mode
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chromatography employs a combination of two or more of these
interaction modes.
Mixed-mode phenomena in the past were considered “sec-
ondary interactions”. Most stationary phases are based on rigid
support matrices such as silica gel or polymers, to which speciﬁc
functional groups (e.g. alkyl chain C18, diol, etc) are bonded. Often
sample solutes interact differently with the matrices and the func-
tional groups, generating “secondary interaction” characteristics
[9]. Mixed-mode IEX and RP interactions can even be observed on
classical silica-based RP columns without intentionally introduc-
ing an ion-exchanger. Free silanol groups on silica gel matrix are
considered as sites of secondary interactions in RP chromatogra-
phy. Similarly, hydrophobic interactions exist in IEX separation,
and ionic interactions exist in SEC separation. While in some cases,
the secondary interactions are considered beneﬁcial for selectivity
[10,11], most of the time it is considered detrimental to a separa-
tion. For example, the free silanol group on silica often contributes
to peak tailing, a phenomenon that is minimized by end-capping
or by optimizing mobile phase conditions.
MMC can retain and separate small, polar drugs and related sub-
stances that are not retained by typical RP HPLC. It has been used as
an alternative method to traditional ion chromatography for coun-
terion analysis [1,12,13]. MMC  has been used for the puriﬁcation
of biological samples and allowing direct sample injection [14–17].
MMC can retain acidic and basic compounds at mild mobile phase
conditions compatible with MS  detection. For a given mixed-mode
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Due to the complexity and variety of analytes in hydrophilic-
A0 K. Zhang, X. Liu / Journal of Pharmaceuti
olumn, the predominant separation mechanism depends on the
roperties of the sample as well as the mobile phase conditions.
he mixed-mode stationary phases introduced in recent years
rovide desirable and repeatable “secondary interaction” or “ter-
iary interaction” with the use of carefully designed functional
roups of different retention modes and well controlled manu-
acturing process. The recent commercialization of mixed-mode
olumns signiﬁcantly advanced the utility of MMC  in pharmaceu-
ical and biopharmaceutical applications [18–23].
Because MMC  is complementary to RP and other separation
odes, mixed-mode columns are also used in two-dimensional
iquid chromatography (2D-LC) [2,24,25]. Furthermore, the multi-
ode retention mechanisms can add dimensionality to a single
ixed-mode column by adjusting mobile phase conditions. There-
ore, mixed-mode columns are frequently used as an alternative
echnique for 2D-LC while using a single column and conventional
PLC setup [5,26,27].
. Stationary phase and separation mechanism
.1. Mixed-mode LC column media
The occurrence of mixed-mode chromatography, including
oth RP and IEX mechanisms, has been known for decades [9].
he use of mixed-mode chromatography for HPLC separations
as been widely reported [18,28–45]. Mixed-mode columns can
e divided into RP/anion exchange (AEX), RP/cation-exchange
CEX), hydrophilic interaction liquid chromatography (HILIC)/AEX
nd HILIC/CEX bimodal phases, as well as RP/AEX/CEX and
ILIC/AEX/CEX trimodal materials. According to their chemistry
esign, bimodal media can usually be classiﬁed into four categories
Fig. 1). Type I media are achieved by mixing different types of par-
iculate separation media, each with a single chemistry, such as RP
r IEC, and packing the mixture into a column [28,29]. Type II media
onsist of substrates modiﬁed at the surface with a mixture of lig-
nds having different functionalities, RP/IEX, HILIC/IEX, or RP/HILIC
30,32,33]. More sophisticated stationary phases can be prepared
sing ligands that contain ion exchange functionality as a part of
he hydrophobic ligand. Depending on the position of the ionizable
unctionality with respect to the pore surface, these phases can be
embedded” (Type III), i.e. the functionality is close to the surface
nd the hydrophobic chain extends in a mobile phase environment
31,34,37], or “tipped”(Type IV) with the functionality at the free
nd of the hydrophobic chain [34,46]. These stationary phases are
Fig. 1. Types of RP/IEX bimodal mixed-mode columns c
dapted from Ref. [47]. Biomedical Analysis 130 (2016) 19–34
advantageous in reproducibility since the chemistry is deﬁned by
the attached ligands, not by the preparation process.
In recent years, mixed-mode stationary phases have received
considerable attention by both academia and industrial research
organizations. Several RP/weak anion-exchange (WAX) materials
consisting of a selector immobilized onto thiol-modiﬁed silica gel
have been reported [38,40–43,46]. In these phases, the WAX  site
is located on the outer surface of the lipophilic layer and is linked
to the hydrophilic silica support via a lipophilic spacer with polar
embedded amide and sulﬁde groups. Currently, Type I and Type
II bimodal columns are not commonly used due to the perfor-
mance limitations. Columns using Types III and IV media have
been commercialized and positioned as both general-purpose LC
columns (as an alternative to C18) and application-speciﬁc prod-
ucts. An example of commercial Type III columns is the Primesep®
column family that each column has a dual chemistry stationary
phase with a hydrophobic long alkyl chain and an ionizable cationic
or anionic embedded group [35–37,48,49]. When the polar group
bears a charge, it effectively shields any other less polar groups of
the stationary phase. As a result, the activity of silanol groups, which
cause unwanted interaction in many reversed-phase columns, is
completely undetectable and does not affect the peak shape or
selectivity. Commercial Type IV bimodal columns are also available,
such as Acclaim® Mixed-Mode WAX-1 [45], Acclaim Mixed-Mode
WCX-1 [18] and Acclaim Surfactant [44]. Structures of some RP/IEX
stationary phases with distinctive chemistry designs are illustrated
in Fig. 2.
In addition to silica-based mixed-mode columns discussed
above, polymer-based mixed-mode HPLC columns are also avail-
able [50,51,52–54]. The multimode separation mechanism of
the OmniPac PAX-500 is achieved by coating a macroporous,
hydrophobic polymer core for RP retention with an anion-exchange
latex bead layer for anion-exchange retention. The macroporous
structure provides an accessible hydrophobic core where reversed-
phase retention occurs. The anion-exchange selectivity is provided
by anion-exchange MicroBeadTM latex that coats the outer layer of
the hydrophobic core. Similarly, the multimode separation mech-
anism of OmniPac PCX-500 is achieved by coating a macroporous
hydrophobic polymer core for RP retention with a CEX latex bead
layer for cation-exchange retention.ity and ionization, it is highly challenging but desirable to separate
anionic, cationic and neutral molecules within a single HPLC anal-
ysis. This separation necessitates trimodal stationary phases that
lassiﬁed by the arrangement of functional groups.
K. Zhang, X. Liu / Journal of Pharmaceutical and Biomedical Analysis 130 (2016) 19–34 21
Fig. 2. Structures of some RP/IEX mixed-mode stationary phases.
Adapted from Ref. [20].
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fig. 3. RP/AEX/CEX trimodal mixed-mode phases. (A) Mixed-beds. Adapted from R
rom  Ref. [55].
an provide CEX, AEX and RP (or hydrophilic) interactions simulta-
eously. Fig. 3A shows that the Scherzo stationary phase by Imtakt
23] is constructed by mixing two types of bonded silica particles:
ne modiﬁed with C18 and CEX functionalities, and the other one
ith C18 and AEX functionalities. These columns are positioned as
eneral-purpose columns for a broad range of HPLC applications
56–58]. SIELC Obelisc R and Obelisc N differ in the type and prox-
mity of their charged groups and the hydrophobicity of their long
hains (Fig. 3B) [58,59]. Obelisc R has cationic groups close to the sil-
ca surface separated from anionic groups by a hydrophobic chain.
belisc N has anions close to the surface separated from cationic
roups by a hydrophilic chain. While Obelisc R is a reversed-phase
nalytical column and can be used in traditional, reversed-phase
ype applications, Obelisc N is a column which has very polar char-
cteristics and works well for polar and charged analytes [21].
The Acclaim Trinity P1 is prepared by Nanopolymer Silica
ybrid (NSHTM) technology through an electrostatically-driven
elf-assembly process. It consists of high-purity porous spherical
ilica particles whose inner-pore area is covalently modiﬁed with
ilyl ligands containing both RP and WAX  moieties while the outer
urface is coated with fully sulfonated nano-polymer beads by
lectrostatic interactions (Fig. 3C) [55]. The synthetic process was
escribed previously [12,58]. First, spherical porous silica particles
re covalently modiﬁed with a silane containing both a hydropho-
ic alkyl chain (for hydrophobic retention) and a terminal tertiary
mine (for weak anion-exchange retention) in the same ligand
o obtain the surface modiﬁed silica particles. Then nanometer-
ized fully-sulfonated polystyrene-divinylbenzene polymer beads
ixed with the modiﬁed silica particles under conditions in which
oth components are ionized, ensuring an electrostatically driven
elf-assembly process. As the size of nano-polymer beads is in the
ange of 1000–3000 Å, much larger than the pore size of silica
articles (300 Å), the charged nanometer-sized polymer beads are
electively and permanently attached to the outer surface area by
lectrostatic attraction, but are excluded from the inner-pore area
ue to steric hindrance. This chemistry design creates a spatial sep-
ration of the AEX and CEX regions, preventing each charged moiety
rom masking the other, and allowing simultaneous RP, CEX and
EX retention. The Acclaim Trinity P2 column stationary phase is
lso based on NSH technology [60], but its inner-pore area is mod-
ﬁed with a covalently bonded hydrophilic layer that also provides
EX retention while the outer surface is modiﬁed with AEX nano-
olymer beads. Acclaim Trinity P2 column provides CEX, AEX and
ILIC retentions simultaneously.
Monolithic stationary phases can also be used for mixed-mode
hromatography separation. The ion exchange functionality is eas-
ly introduced into the polymer monolith by copolymerizing the
unctional monomers with the cross linkers. Methacrylic acid]. (B) Single ligand. Adapted from Ref. [21]. (C) Nanopolymer silica hybrid. Adapted
has been copolymerized with 2-hydroxyethyl methacrylate and
ethylene dimethacrylate to produce a monolith with hydrophilic
interaction and weak cation exchange (WCX) capabilities [61].
Strong anion exchange (SAX) can be introduced by copolymer-
izing 2-(methacryloxy)ethyltrimethylammonium methyl sulfate
with different crosslinkers to generate mixed-mode RP/SAX [62]
or HILIC/SAX [63] monoliths. Alternately, the IEX functionality
can be introduced to the monolith by a surface modiﬁcation
approach. Silica-based mixed-mode monoliths are usually obtained
by modifying the monolith surface with desired functionalities. For
instance, amine groups have been attached on monolithic silica to
create a RP/WAX mixed-mode phase [39,64]. A new approach was
recently reported for the preparation of monolithic mixed-mode
stationary phases for protein separation [65]. As shown in Fig. 4,
the surface of monolithic poly(glycidyl methacrylate-co-ethylene
dimethacrylate) capillary columns was  functionalized with thiols
and coated with gold nanoparticles. The ﬁnal mixed-mode surface
chemistry was formed by attaching, in a single step, alkanethiols,
mercaptoalkanoic acids, and their mixtures on the free surface of
attached gold nanoparticles. Use of these mixtures allowed ﬁne
tuning of the hydrophobic/hydrophilic balance.
The MMC  technology for antibody puriﬁcation was developed
in the late 1950s with hydroxyapatite [66,67]. The following gener-
ations of mixed-mode media were developed after 1970 and were
used in many applications [68–71]. In the 1980s, these resins were
widely used for the puriﬁcation of nucleic acids rather than the pro-
tein puriﬁcation ﬁeld. The pioneering work of Burton and Harding
started the era of using “Hydrophobic Charge Induction Chro-
matography” or mixed-mode chromatography to purify proteins
[72]. They tested numerous ligands having heterocycles known for
their hydrophobicity and demonstrated that the combination of
hydrophobic and ionic interactions offered new selectivity. Since
then, MMC  has been used to evaluate the performance of for mAb
puriﬁcation that does not involve protein A [73–78].
MMC using multimodal functional ligands can adsorb target
proteins with the combination of ionic interactions, hydro-
gen bonds and hydrophobic interactions [79–81]. Mixed-mode
resins can directly capture target proteins at relatively high salt
concentration without dilution or other additives due to their
multiple binding interactions. Currently, commercially available
mixed-mode resins include Capto MMC,  Capto adhere and Capto
Core 700 from GE Healthcare, PPA Hypercel, HEA Hypercel and
MEP  Hypercel from Pall Corporation, Eshmuno HCX from Merck
Millipore, Toyopearl MX-Trp-650 M from TOSOH Bioscience, and
Nuvia cPrime, CHT Ceramic Hydroxyapatite, and CFT Ceramic Flu-
oroapatite from Bio-Rad. Varying properties of these resins such as
static and dynamic binding properties [82,83], adsorption kinetics
[84], adsorption selectivity [85], ligand design and molecular
K. Zhang, X. Liu / Journal of Pharmaceutical and Biomedical Analysis 130 (2016) 19–34 23
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dapted from Ref. [65].
imulation [80,86–88] and applications [89–92] have been
eported in literature.
The column chemistry of Capto MMC,  Capto adhere and Capto
ore 700 from GE Healthcare is shown in Fig. 5A. Capto MMC  is a
ultimodal cation exchanger with WCX  interaction, hydrophobic
nteraction, hydrogen bonding, and thiophilic interaction [93].
he combined effects of these interaction modes give the media
ovel selectivity and make it tolerant to high salt. Capto adhere
s a SAX mixed-mode medium provided by N-benzyl-N-methyl
thanolamine functionality. It provides several interactions with
roteins including electrostatic interaction, hydrogen bonding,
nd hydrophobic interaction [6,93]. Capto Core 700 ligand is found
nly in the core of the beads. The Capto Core concept shown in
ig. 5B is based on a bead with a nonfunctionalized outer layer
without ligand) and a functionalized core with an attached ligand.
his design combines properties of gel ﬁltration and adsorption
hromatography. The bead’s pores in the outer layer, with an
pproximate exclusion limit of 700 kD, have been speciﬁcally
esigned to exclude large molecular entities such as viruses, DNA,
arge protein, or protein complexes from entering the internal
pace, while small protein impurities can enter the interior of
he matrix particle and bind to the ligand, thereby enabling an
fﬁcient ﬂow-through puriﬁcation step. The core of each bead
s functionalized with octyl amine that is both hydrophobic and
ositively charged (at pH < 10), resulting in a highly efﬁcient mul-
imodal binding of various impurities over a wide range of pH and
Fig. 5. GE Capto staionary phases. (A) Structures of Capto MMC,  Capto adhere and Ca
dapted from Ref. [19].d its modiﬁcations with cystamine, reduction with tris(2-carboxylethyl)phosphine,
salt concentrations. This novel core bead technology gives Capto
Core 700 a dual functionality with restricted access, combining
size separation and multimodal binding [19].
Other forms of MMC  have also been used for the separations of
bio-molecules. High salt concentrations are often used to promote
hydrophobic interactions between proteins and mildly hydropho-
bic surfaces. Studies have been done using SEC columns with a
neutral hydroxyl functionality (e.g. diol) to separate monoclonal
antibodies, the aggregates, or bispeciﬁc hybrids not only based on
size, but also based on hydrophobic interactions resulting from the
addition of salt to the mobile phase [3,17]. Zirconia based RP/IEX
mixed-mode column [94] and ionic liquid HILIC/AEX MMC  [95]
have also been reported.
2.2. Mixed-mode SPE media
Mixed-mode chromatography has also been used for solid-
phase extraction (SPE) sample preparation [96,97]. Most
mixed-mode SPE media are polymer-based sorbents modi-
ﬁed with ion-exchange groups, which typically enables RP and
IEX interaction mechanisms. The introduction of IEX interaction
allows the selective extraction of target species or the elimination
of interference by adjusting the charge state of analytes and/or
sorbents with mobile phase pH change. Mixed mode SPE is mainly
used to clean-up samples, pre-concentrate targets, reduce matrix
effects, and selectively extract acidic, neutral and basic analytes
pto Core 700. (B) Schematic cross-sectional view of a Capto Core 700 particle.
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rom complicated samples, including environmental wastewater,
ood, and biological ﬂuids.
Mixed-mode SPE media are constructed by modifying conven-
ional polymer sorbents, such as polystyrene (PS)–divinylbenzene
DVB) or high-surface-area DVB-based particles, with different
EX functionalities, including quaternary ammonium, sulfonic acid,
mino, and carboxylate groups, for example of Thermo Scien-
iﬁc Dionex SolEx SPE cartridates. To achieve efﬁcient extraction
f polar analytes, ﬁrst the apolar PS-DVB particles are modiﬁed
ith polar groups such as hydroxyls, and then are modiﬁed with
onic functionalities, for example of Biotage EVOLUTE® EXPRESS
PE columns [98]. The polar groups counter the hydrophobicity
f PS-DVB, imparting a balance of hydrophilicity and lipophilicity,
nd the ionic functionalities impart IEX characteristics. Strata-X is
ased on pyrrolidone-modiﬁed PS-DVB which is further modiﬁed
ith ionic groups. Strata-X-C contains a sulfonate group, Strata-
-CW contains a carboxylate group, and Strata-X-AW contains a
iamine group [99]. Another class of the commonly-used mixed-
ode SPE products is based on the copolymerization of lipophilic
VB and hydrophilic N-vinylpyrrolidone followed by modifying the
urface with IEX functionalities to produce Oasis WCX  (carboxylic
cid), Oasis WAX  (piperazine group), Oasis SCX (sulfonate group)
nd Oasis SAX (quaternary amine) [100–110]. The ionic groups
an also be introduced by copolymerizing a functional monomer
ith cross linkers. The imidazole group in N-vinylimidazole (NVIm)
DVB copolymer not only improves the sorbent hydrophilicity,
ut also introduces an adjustable ion-exchange functionality as
t can be protonated by decreasing the pH [111]. 2-Acrylamido-
ethylpropane sulfonic acid (AMPSA) can be copolymerized with
-hydroxyethyl methacrylate (HEMA) and pentaerythritol triacry-
ate (PETRA) to introduce SCX groups onto the polymer sorbent
112].
Mixed-mode SPE products can also be achieved by packing a
ixed bed of a special, non-polar C8 sorbent and a strong cation
xchanger (e.g. Agilent Bond Elut Certify), or of a non-polar C8 and
trong anion exchange sorbent (e.g. Agilent Bond Elut Certify II),
r by packing strong cation exchange (SCX) and a strong anion
xchange (SAX) sorbent packed into one bed (e.g. Agilent Accu-
AT) [99,113]. Graphite carbon/strong cation exchange (CARB/SCX)
ixed-mode SPE has also been explored for simultaneous determi-
ation of cyanuric acid (CYA) and melamine (MEL) in dairy products
114].
Solid-phase microextraction (SPME), is a solid phase extraction
ampling technique in which a ﬁber coated with a solid sorbent
r polymeric liquid extracting phase is used to sorb a variety of
olatile and non-volatile analytes from liquid or gas phase samples.
ixed-mode SPME ﬁbers coated with C18/propylsulfonic function-
lities have been used for extraction of freely dissolved basic drugs
amitriptyline and amphetamine) [115,116].
.3. Separation mechanism
The retention of IEX/RP based mixed-mode stationary phases
s the result of combination of RP, IEX and ion-exclusion interac-
ions. The relative contribution of each mechanism depends on the
ydrophobicity and charge state of solutes as well as chromato-
raphic conditions such as mobile phase ionic strength, pH and
rganic solvent composition. A simple empirical stoichiometric dis-
lacement model can be used for discussion [117–119]. According
o this model, plots of log k versus log counter-ion concentration
C) are linear, according to the following equation [117]:og k = log KZ − Zlog C
herein k is retention factor, KZ is a constant related to the ion-
xchange equilibrium constant and the ion-exchange capacity and Biomedical Analysis 130 (2016) 19–34
Z is the ratio of the valencies of solute ion (s) and counter-ion (c)
(Z = s/c). The empirical linear relationship between log k and log
C indicates the degree of ion exchange activity in a separation.
The slope Z indicates the number of charges involved in the ion-
exchange process, whereby for a monovalent counter-ion the slope
is representative for the charge on the solute. In general, all mech-
anisms function independently, and can be modiﬁed as needed by
adjusting mobile phase ionic strength, salt type, pH, and organic
solvent content [40–43,46].
Mixed-mode stationary phases can be operated in a variety
of chromatographic modes, including RP mode (e.g. for neutral
molecules), IEX mode (for solutes bearing the opposite charge),
ion exclusion chromatography mode (for solutes having the same
charge), and HILIC mode (polar neutral, basic, amphoteric, and
acidic compounds), depending on the chromatographic conditions
and the characteristics of the analytes. While a number of studies
on retention behavior and applications in RP/IEX modes have been
reported, investigations of RP/IEX mixed-mode columns in HILIC
mode have been scarce. Recently, retention behaviors of RP/IEX
mixed-mode columns in mobile phases with high acetonitrile con-
tent have been the subject of research of academia and industrial
research [40,42,43,46,58]. To test the existence of HILIC mechanism
in mixed-mode columns, methanol was  used as the mobile phase
organic solvent as opposed to acetonitrile. Methanol is a strong
solvent in HILIC, so comparing its retention vs. solvent content
behavior for a group of anlytes to that generated from acetoni-
trile will provide useful information for better understanding the
retention mechanism of mixed-mode columns in high organic sol-
vent conditions. Liu and Pohl investigated the retention behavior
of a commercial trimodal mixed-mode column – Acclaim Trin-
ity P1, using three model probes – uracil (neutral), sodium ion
(cationic) and nitrate (anionic), in both acetonitrile/ammonium
acetate and methanol/ammonium acetate buffer systems [12]. At
higher solvent levels (>80%), acetonitrile exhibited signiﬁcantly
higher retention for uracil and sodium ion compared to methanol.
For nitrate, a similar observation was  noted at a 90% solvent level.
Because no HILIC behavior is expected in a methanol/aqueous
mobile phase, the increase in retention with increasing levels of
acetonitrile is a clear indication of the HILIC effect. At 90% ace-
tonitrile, retention decreased for charged analytes such as sodium
and nitrate, indicating the presence of both ion-exchange and HILIC
processes existed with the HILIC mechanism.
Due to the presence of polar IEX functionality, modern RP/IEX
mixed-mode columns are capable of operating in high organic sol-
vent HILIC mode conditions. Although more studies are needed to
thoroughly understand the retention mechanism of RP/IEX mixed-
mode columns under HILIC conditions, the existing evidence
suggests a retention mechanism consisting of an electrostatic inter-
action superimposed on a HILIC interaction for highly hydrophilic
ionic analytes, and a solely HILIC interaction for highly hydrophilic
neutral molecules. Owing to the presence of a hydrophobic moiety,
the polarity of the RP/IEX surface imparts intermediate RP interac-
tion strength, but substantial retention for charged analytes can be
realized via IEX interaction. As a result, retention of charged ana-
lytes can be tuned by adjusting mobile phase pH and ionic strength
while the retention of neutral analytes is governed solely by the
mobile phase solvent content [1].
3. Applications in pharmaceutics and biopharmaceutics
3.1. CounterionsMixed-mode chromatography has gained great popularity in
pharmaceutical counterion analysis in recent years [1,120,121].
Among active pharmaceutical ingredients approved by FDA, half of
K. Zhang, X. Liu / Journal of Pharmaceutical and Biomedical Analysis 130 (2016) 19–34 25
Fig. 6. Chromatogram of the 25 common pharmaceutical ions separated by mixed-mode chromatography with charged aerosol detector. Peak identiﬁcation: 1 = lactate,
2  = procaine, 3 = choline, 4 = tromethamine, 5 = sodium, 6 = potassium, 7 = meglumine, 8 = mesylate, 9 = gluconate, 10 = maleate, 11 = nitrate, 12 = chloride, 13 = bromide,
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n4  = besylate, 15 = succinate, 16 = tosylate, 17 = phosphate, 18 = malate, 19 = zinc, 20 
dapted from Ref. [1].
hem are in the salt forms [122]. This is due to improved solubility,
urity and polymorphism in the salt forms and the resulting gains in
rug pharmacodynamics, pharmacokinetics and stability. Counter
on analysis is a key task in pharmaceutical research and quality
ontrol. Ion analysis is one of the most popular applications of
ixed-mode chromatography. One big attraction of using mixed-
ode chromatography for ion analysis is that conventional HPLC
an be used, with need to purchase and maintain a dedicated ion
hromatography (IC) system, typically requiring specialized mobile
hase, cation or anion IEX column, ion suppressor, and a conductiv-
ty detector. Due to the low UV-absorption of most pharmaceutical
ounter ions, CAD and ELSD detectors are typically coupled with
he mixed-mode LC for their analysis. When using an appropri-
te MMC  column, there is no need to have separate methods for
ations and anions, which calls for different ion exchange columns
nd instrument conﬁguration by IC.
Huang and coworkers previously [121] reported the separation
f inorganic counterions using Sequant ZIC-pHILIC columns by two
ifferent methods based on the analyte valence. A 150-mm column
ith pH 7.0 ammonium acetate buffer/acetonitrile (25/75) mobile
hase was used in the analysis of monovalent ions such as NO3−,
l−, Br−, Na+ and K+. A 50-mm column with pH 3.5 ammonium
ormate/acetonitrile (30/70) mobile phase was used for multiva-
ent ions such as Ca2+, Mg2+, SO42− and PO43−. Better accuracy was
bserved for Cl− in several drug substances when compared to IC. A
eQuant silica based zwitterionic column ZIC-HILIC operated in the
ILIC mode in conjunction with evaporative light scattering detec-
ion was also used for the separation of pharmaceutical counterions
120]. A SeQuant polymeric zwitterionic column ZIC-pHILIC was
lso reported for the simultaneous analysis of cations and anions
120].
Simultaneous separation of pharmaceutical counterions has
een signiﬁcantly improved in recent years, attributed to the
ecent advance and commercialization of mixed-mode column
echnologies [47] [12]. As shown in Fig. 6, using the mixed-mode
cclaim Trinity P1 column separation and CAD detection, Zhang
nd coworkers developed a generic method for simultaneous sep-
ration of 25 commonly used pharmaceutical counterions within
0 min, including cation and anion, inorganic and organic ions in
he same run [1]. As describe earlier, Trinity P1 is a silica based col-
mn with the mixed modes of RP/CEX/AEX interactions. The effects
f mobile-phase organic strength, buffer ions, ionic strength, pH
nd column temperature were investigated to optimize the method
s well as to understand the retention and separation mecha-
isms. The anions studied were chloride, sulfate, bromide, maleate,nesium, 21 = fumarate, 22 = tartrate, 23 = citrate, 24 = calcium, 25 = sulfate.
mesylate, tartrate, citrate, phosphate, fumarate, nitrate, lactate,
succinate, besylate, malate, gluconate, tosylate. The cations stud-
ies were sodium, calcium, potassium, meglumine, tromethamine
(Tris), zinc, magnesium, procaine and choline. Signiﬁcant physi-
cochemical property differences between counterions and active
pharmaceutical ingredients (API) permits complete separation of
API and counterions with no interference from API matrix. Fig. 7
shows the separation of counterions and their APIs. The method
showed good linearity in the deﬁned range and the accuracy was
in the range of 99.0–101.0% with %RSD less than 2.0%. This method
was adopted and further validated by the laboratory department
of the European Pharmacopoeia (Ph. Eur.) and applied to the coun-
terion identiﬁcation and quantiﬁcation in drug substances as well
as for the control of inorganic ions as impurities [13]. Method
performance was  demonstrated by analysis of Ph. Eur. reference
standards and pharmaceutical substances (e.g. cloxacillin sodium,
somatostatin). This method can easily be coupled to a mass selec-
tive detector without any modiﬁcation for identiﬁcation of API as
well as organic ions.
3.2. Active pharmaceutical ingredients and related substances
In the area of small molecule API analysis, RP columns still
dominate the applications, but MMC  has been used for polar and
charged API molecules that typically cannot be handled by RP
columns [123–125]. Bisphosphonates are a class of drugs that
prevent the loss of bone mass. The analysis of bisphosphonate
has been challenging because of these molecules are polar, ionic
and most of them do not have a UV chromophore. Pre-column
derivatization, indirect UV analysis, ion-pair and capillary elec-
trophoresis (CE) methods have been used to separate and detect
these molecules. Etidronate, (1-hydroxyethylidene) bisphospho-
nate, and its impurities phosphate and phosphite do not have a
UV chromophore and are highly ionic, so it is difﬁcult to separate
these compounds by conventional HPLC columns and detected by
ordinary spectrophotometric methods. Liu et al. developed a stabil-
ity indicating method for the analysis of etidronate disodium and
its related substances by using a mixed-mode column (Primesep
SB) and charged aerosol detector [123]. Good sensitivity, accuracy
and precision were demonstrated for etidronate and its impuri-
ties. Analysis of atovaquone, proguanil and related compounds in
the antimalarial combination drug Malarone was  accomplished
using a mixed-mode column composed of 50% C18 and 50% strong
cation exchanger and UV detection [126]. A RPLC/HILIC mixed-
mode stationary C18-DTT (dithiothreitol) silica prepared through
26 K. Zhang, X. Liu / Journal of Pharmaceutical and Biomedical Analysis 130 (2016) 19–34
Fig. 7. Chromatograms of the separation of active pharmaceutical ingredients and their counterions by mixed-mode chromatography and CAD detector. (a) adenine
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dapted from Ref. [1].
thiol-ene” click chemistry was recently reported [127]. The appli-
ation of the C18-DTT column was demonstrated in the separation
f non-steroidal anti-inﬂammatory drugs, aromatic carboxylic
cids, alkaloids, nucleo-analytes and polycyclic aromatic hydro-
arbons. The MMC  retention behaviors of Waters CSH (charged
urface hybrid) stationary phases for ten pharmaceutical com-
ounds encompassing acids, bases and neutral were reported [128],
ven though CSH is not marketed as mixed-mode. It was found the
SH stationary phases represent a selectivity tool preferably for
eparation of basic compounds.
MMC  separations have been used in the analysis of challeng-
ng analytes in complex biological matrices. Cytarabine (ara-C), an
nticancer agent, is highly polar and not retained on the column
y typical RP chromatographic conditions. Hsieh et al. developed
 mixed-mode HPLC-APCI-MS/MS assay for the determination of
ytarabine in mouse plasma using a SIELC Primesep A RP/IEX
olumn (3.2 mm × 50 mm)  and a simple sample treatment pro-
edure [124]. MMC  C18/SCX was reported for determination of
ropranolol and furosemide in human plasma [129]. S-propargyl-
ysteine (SPRC), a cardioprotective agent, is a sulfur-containingamino acid derivative. Like most amino acids, SPRC is highly polar
and difﬁcult to extract from biological matrices. It may  also co-
elute with endogenous, polar substances when use conventional RP
chromatography. Zheng et al. applied a MMC  method for the deter-
mination of SPRC pharmacokinetics in rats [125]. In this method, a
CAPCELL PAK CR 1:4 (150 mm × 4.6 mm)  mixed-mode RP/CEX col-
umn containing C18 bonded silica particles and sulfonic acid CEX
particles was used. The assay utilized methanol to achieve a simple
and fast deproteinization and the MS  quantiﬁcation was  operated
in multiple reactions monitoring (MRM)  mode.
Phosphorylated carbohydrates are important metabolites in
various central metabolic pathways. Chromatographic separation
of individual isomeric forms of phosphorylated carbohydrates
is critical as these isomers give similar fragmentation patterns
and cannot be distinguished by MS/MS  detection. However, the
chromatographic separation and detection is challenging because
of the hydrophilicity of phosphorylated carbohydrates and lack
of strong UV-absorbing groups, which is characteristic of most
carbohydrates. Hinterwirth et al. [130] reported the separation
of isomeric sugar phosphates by RP/WAX mixed-mode column
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nd charged aerosol detector. The stationary phases used were
-aminoquinuclidine-derived and 3--aminotropane-derived
P/WAX mixed-mode columns. Optimal results were obtained
hen the column was operated under HILIC mode. Acidic con-
itions led to the complete separation of - and -anomers of
lucose 6-phosphate at low temperature.
Restricted access columns allow large molecules to pass through
he column quickly by hindering their access to the surface
ith bulky hydrophilic groups, while the small drug molecules
re retained by interaction with the bonded hydrophobic group
16,131]. This type of columns is not expected to offer large
late numbers for compound separation, but it provides sufﬁ-
ient chromatographic efﬁciency for high speed LC–MS analysis.
irect injection of biological samples is desired to eliminate
ime-consuming cleanup steps and increase analytical accuracy.
ormally, direct injection methods utilize dual-column LC sys-
ems that need one extraction column for online puriﬁcation
ollowed by an analytical column for chromatographic separa-
ion. By using MMC,  a single column can perform all the functions
equired for direct sample analysis. Hsieh et al. applied a polymer-
oated mixed-function (PCMF) column CAPCELL MF  C8 for direct
nd simultaneous LC–MS/MS analysis of two drug candidates in
onkey plasma samples [15]. Fleming [16] applied Supelco mixed-
ode column Hisep for the quantiﬁcation of free maytansinoid
rug in DM1 antibody drug conjugate (ADC).
.3. Impurities
MMC  is very useful in pharmaceutical impurity proﬁling,
specially for complex impurities with diverse physicochemical
roperties such as hydrophobicity, polarity and charge status.
imultaneous determination of four related impurities in a devel-
pmental Drug A was reported using a SIELC mix-mode RP/CEX
rimesep 200 column [8]. The four impurities are quite structurally
iverse, including a small ionic compound aminoglutarimide
ydrochloride, a neutral compound containing aromatic nitro and
lutarimide functional groups, and two zwitterion degradants that
re geometric isomers containing aromatic amine and glutamine.
he charged degrandants and Drug A were retained by both IEX
nd RP partitioning mechanisms, the small ionic compound was
rimarily retained by IEX, and the neutral compound was  retained
hrough RP partitioning without IEX. Method selectivity, sensitivity
nd accuracy have been demonstrated to be suitable to determine
he related impurities in the capsules of Drug A.
Impurities in drug substance and drug product can also be car-
ied from raw materials, upstream synthesis or other sources of
ontamination. For example, lithium containing reagents are fre-
uently used in drug synthesis process and can be carried into ﬁnal
rug products. High level of lithium in blood could pose serious
ven lethal toxicity, so it is very important to accurately quan-
ify residual lithium. Dai et al. recently reported a new approach
o determine lithium by using MMC  Acclaim Trinity P1 column
oupled with CAD [132]. High sensitivity was achieved by sys-
ematically studying the retention behaviors of lithium, potential
nterfering ions and different type of pharmaceutical API matri-
es under RP, HILIC and CEX/AEX mechanisms, and selecting the
hromatographic conditions that effectively reduce the interfer-
nces. Samples were directly analyzed without pretreatment such
s derivatization and extraction.
By using a single mixed-mode column Acclaim Trinity P1 in con-
unction with dual sample injections with different mobile phases
n each run, Kazarian and coworkers were able to comprehensively
eparate hydrophobic and hydrophilic APIs, their counter-ions
organic, inorganic) and excipients and detect them with both UV
nd refractive index detectors [26]. RP and IEX interaction condi-
ions were applied in the ﬁrst injection run using a mobile phase Biomedical Analysis 130 (2016) 19–34 27
consisting of a dual organic modiﬁer/salt gradient to separate API,
counter-ions and an unknown degradant. HILIC conditions under
high organic solvent mobile phase were applied in the second sam-
ple injection run to provide retention of the saccharide excipients.
The method was  applied to the analysis of two  pharmaceutical
dry powder inhalers formulations Flixotide® and Spiriva®, which
respectively contained ﬂuticasone propionate or tiotropium bro-
mide, and lactose excipient.
In a following study, Kazarian et al. [5] coupled a mixed-bed col-
umn  and a HILIC column with dual sample injections and used three
detectors in series, UV-conductivity- RI to proﬁling the compo-
nents of pharmaceutical formulations including Robitussin® cough
syrup. A switching valve was used after the pump to switch the
mobile phase between two columns. The mixed-bed column Imtakt
Scherzo SS C18 provided separation of inorganic anions and cations
under isocratic conditions, followed by a dual organic/salt gradient
to elute APIs and their respective organic counterions and poten-
tial degradants. Then, the mobile phase ﬂow was switched to the
HILIC column Shodex Asahipak NH2P-50 4E and the samples were
re-injected for the separation of hydrophilic excipients carbohy-
drates. In this respect, MMC  is somewhat like 2D-LC. Additional
separation dimension can be added even using the same single col-
umn, but changing the mobile phases according to the separation
and retention purpose. Wang and coworkers developed a mixed-
mode C18/Diol column and applied it to the proﬁling of the extract
of traditional Chinese medicine Lonicera japonica [27]. A single col-
umn  and a conventional HPLC were used with the addition of a
six-port, two-position valve controlled sample loop. RP separation
mobile phase condition was  applied ﬁrst, and the poorly retained
co-eluting hydrophilic components of the extract of Lonicera japon-
ica were collected into the sample loop and re-injected online
for the second step HILIC separation by conveniently varying the
mobile phase components.
Mixed-mode SPE systems are often more advantageous and
provide better separation than standard RP or IEX sorbent sys-
tems alone. Mixed-mode SPE is a simple but powerful technique
to quickly extract and concentrate impurities for MS  structure
identiﬁcation of pharmaceutical impurities and degradations, espe-
cially for drug forced degradation and excipient compatibility
studies. Landis reported the protocols of using mixed-mode CEX
SPE Oasis MCX  cartridges and AEX SPE Oasis MAX cartridges, and
applied them to identify the degradation products and understand
the degradation pathways of the hydrolysis of pharmaceutical
compounds benzocaine and bezaﬁbrate and oxidation of chlor-
promazine and benzocaine [133].
3.4. Formulation excipients
Many formulation excipients are highly water soluble and/or
charged, so typically they are not retained well on the RP columns
and elute at the void volume. Using mixed-mode column to retain
and separate these excipients in the presence of high concentration
of drug matrix has gained increasing attention in recent years.
Non-ionic surfactants such as polysorbate 20 or 80, in the trade
name as Tween 20 or 80, are commonly used in protein drug
formulations as excipients or vehicle to increase drug solubility
and stability. Due to the strong interference from the high con-
centrations of proteins and the molecular heterogeneity nature of
the polysorbates, the quantitation of polysorbates in protein drug
formulations has been challenging and typically requires lengthy
sample preparation. Hewitt et al. developed a method using a
mixed-mode stationary phase Waters Oasis MAX  (mixed-mode
anion-exchange and reversed-phase sorbent) and evaporative light
scattering detection (ELSD) detector to quantify the total polysor-
bate in protein formulations [134,135]. Proteins are not retained in
the Oasis Max  column because of electrostatic repulsions from the
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uaternary amine in the mixed-mode resin. Hydrophobic polysor-
ate 20 is retained, eluted with a step gradient and quantiﬁed as a
ingle peak. The assay method was qualiﬁed using two  monoclonal
ntibodies (mAbs) in terms of accuracy (96–108%), repeatability
2.3% RSD) and linearity (r2 > 0.999). A total of 25 unique proteins
anging from 25 to 150 kDa were analyzed with this assay.
Mixed-mode column was used in the ﬁrst dimension of a multi-
imensional UHPLC-CAD-MS method to separate the interference
rom the high concentration of mAbs to further characterize the
eterogeneity and stability of polysorbate 20 [24]. A Waters Oasis
ax column that has both anion-exchange and reversed-phase
roperties was used in this study. A two-step elution was employed,
ith the acidiﬁed high aqueous mobile phase used in the ﬁrst step
o wash out the positively charged proteins while retaining the neu-
ral polysorbate, and a high organic mobile phase in the second step
o elute all of the polysorbate esters.
He and coworkers used on-line coupling of a size exclusion col-
mn  with a mixed-mode column for the comprehensive proﬁling
f biopharmaceutical drug products [2]. Proteins and excipients
ere separated by a SEC column. A switching valve was  used after
he SEC column to switch the later eluted excipient peak into the
rinity P1 mixed-mode column to separated different excipients
ncluding cations Na+ and K+, anion Cl−, nonionic hydrophobic sur-
actant polysorbate 80 and hydrophilic sucrose. The applications of
he method were demonstrated in the analysis of mAb, ADC and
accine drug product samples.
MMC  can add dimensionality to a separation by using a single
olumn with stepped mobile phase elution program that promote
 certain interaction mode in a certain elution step. In this respect,
CC is an alternative technique for 2D-LC. Kazarian and cowork-
rs used a single Acclaim Trinity P1 column and a dual injection
pproach to comprehensively separate APIs, their counter-ions,
egradation products and excipients by the combined separation
odes of RP, IEX and HILIC [26]. A dual buffer and organic sol-
ent gradient was used to elute API, counter-ions and an unknown
egradant. A second sample injection was applied in the middle
f the chromatographic run when the high organic buffer HILIC
ondition was established on the column, so the retention of the
xcipient lactose was achieved. The method was applied to two
harmaceutical formulations Flixotide and Spiriva.
.5. Drug in environmental samples
Mixed-mode solid phase extraction has found a large applica-
ion in the analysis of drugs in environmental samples. MMC  is used
s the sample cleaning and concentrating tool to remove matrix
nterference and increase method sensitivity. Most of the published
ethods for the determination of illicit drugs in water environmen-
al samples employ SPE as the pre-concentration technique. Oasis
CX [7,22,136] and Oasis MAX  [22] [137] are used frequently to
xtract the drug followed by LC–MS analysis. New mixed-mode
PE material has also been applied [138].
Gonzalez-Marino et al. developed a selective mixed-mode SPE
nd LC-QTOF-MS method for the simultaneous determination of 24
rugs of abuse and metabolites in urban sewage samples [7]. Ana-
ytes were concentrated using mixed-mode Oasis MCX  sorbents,
mproving the selectivity and sensitivity for basic drugs by adopting
 fractionated elution strategy, which allowed a signiﬁcant reduc-
ion of matrix effects observed during electrospray ionization of
asic drugs.
By using a similar approach, Casado et al. assessed the capabil-
ty of the OASIS MCX  sorbent for the extraction of basic antimycotic
rugs from environmental water samples [136]. It was  found the
ixed-mode SPE improved the selectivity of the concentration pro-
ess, in comparison with the RP sorbents. The use of a sequential
lution SPE protocol allowed the removal of neutral and acidic Biomedical Analysis 130 (2016) 19–34
interferences in the sample which led to a signiﬁcant reduction of
ion suppression and variation during electrospray ionization. The
mixed-mode SPE protocol followed by LC-QTOF-MS determina-
tion provided LOQs low enough for the selective and unambiguous
determination of target compounds in sewage treatment plants,
such as ﬂuconazole, clotrimazole, ketoconazole and miconazole,
and the non-target antimycotic drug climbazole.
A recent study reported the simultaneous determination of six
non-steroidal anti-inﬂammatory drugs (NSAIDs) in environmen-
tal water samples by mixed-mode SPE and LC-QTOF-MS [137].
The method involved an off-line mixed-mode (RP/SAX) SPE for
the selective concentration of COXIBs. It was  found the use of a
strong SAX sorbent (Oasis MAX) led to a signiﬁcant reduction of
matrix effects, during electrospray ionization (ESI), in compari-
son with results obtained for mixed-mode WAX  sorbent (Oasis
Wax) and polymeric RP sorbent (Oasis HLB and Strata X). Among
the pharmaceuticals investigated, celecoxib and etoricoxib were
detected at low levels (ppt) in treated and raw wastewater samples,
and two metabolites carboxylated celecoxib and the hydroxylated
etoricoxib were also found.
3.6. Drug in biological samples
In addition to using MMC  as primary analytical columns to ana-
lyze small molecule drugs in biological samples [15,125,129] as
discussed in Section 3.2, clean up the biological matrix interference
using mixed-mode SPE is an effective way  to sensitively determine
drugs in biological samples. Murkitt et al. earlier reported the use
of a mixed mode SPE followed by RPLC-UV to assay GR117289X
(an angiotensin II receptor antagonist) in human plasma [139].
The mixed-mode SPE Bond Elut Certify II@ employed is a chemi-
cally modiﬁed silica gel material supporting three different types
of interactions: hydrophobic, polar and anion ion exchange. The
extraction procedure has been fully automated by a Zymate XP
robot and linked on-line to the HPLC system. The extraction efﬁ-
ciency of the assay was  approximately 75%. The assay method was
applied to the analysis of GR117289X in plasma of volunteers from a
number of clinical studies and has been shown to be robust in sus-
tained use over several months. Determination of dopamine and
3,4-dihydroxyphenylacetic acid in mouse striatum using mixed-
mode RP/CEX column CAPCELL PAK CR followed by LC-ﬂuorescence
detection was reported [140].
Mixed mode SPE sample treatment can signiﬁcantly reduce
the matrix interference during MS  analysis and improve drug
recovery. SPE-LC–MS has been applied to the identiﬁcation and
determinations of metoprolol and its metabolites in horse urine
and blood [141], nicotinic acid in plasma [142], opioids, cocaines,
amphetamines and adulterants in human blood [143], cytara-
bine in mouse plasma [124], corticosteroids in bovine milk [144],
and paroxetine, ﬂuoxetine and norﬂuoxetine in ﬁsh tissues [145].
Gaboxadol is a small, polar compound and a zwitterion. Attempts
to develop an applicable method for bioanalysis utilized a time con-
suming pre-column derivatization. Kall et al. extracted gaboxadol
from plasma by mixed mode solid phase Waters Oasis MCX  extrac-
tion and then analyzed it on an Asahipak NH2P HPLC column under
HILIC condition with tandem MS  [146]. The validated method was
applied to the quantitative determination of gaboxadol in human
heparinized plasma.
SPE using Biotage Evolute CX mixed-mode resin cartridges
was reported for clean up the blood samples, and combined
with LC–MS using QTRAP mass spectrometry in MRM mode
and product ion spectra in the linear ion trap mode for opi-
oids, cocaines, amphetamines and adulterants analysis [147]. The
cartridge is a mixed-mode resin based cation exchange SPE sor-
bent with an optimized pore size that minimizes retention of
high molecular weight matrix components. a number of 18 drugs
K. Zhang, X. Liu / Journal of Pharmaceutical and Biomedical Analysis 130 (2016) 19–34 29
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ere analyzed in human blood, including morphine, codeine, 6-
onoacetylmorphine, cocaine, benzoylecgonine, dihydrocodeine,
ocaethylene, 3,4-methylenedioxyamphetamine, ketamine, 3,4-
ethylenedioxymethamphetamine, pseudoephedrine, lignocaine,
enzylpiperazine, methamphetamine, amphetamine, methadone,
henethylamine and levamisole.
Recently a mixed-mode C18/SCX SPME coating that com-
ines octadecyl and propylsulfonic acid groups as strong cation
xchange sites, was used to measure freely dissolved concentra-
ions of cationic drugs amitriptyline, amphetamine, diazepam and
ramadol to different binding matrices, including bovine serum
lbumin (BSA), human serum albumin (HSA), human plasma and
uman whole blood [148].
.7. Peptides
Mixed-mode column separation of peptides was  recognized
y Hancock in 1981 [10] during the development of RP station-
ry phases, which contains signiﬁcant concentrations of both free
ilanol and hydrocarbon groups. Zhu et al. reported the mixed-
ode HILIC/SCX separation of peptide when using SCX columns
149,150]. Bell et al. [151,152] explored the ion-exchange charac-
eristic of a pentaﬂuorophenylpropyl-bonded phase (Discovery HS
5) and reported a “U-shape” relationship between retention and
rganic modiﬁer percentage; the ion-exchange properties were
ttributed to the ionized silanols of the stationary phase. Gilar [153]
eported a silica sorbent with a pentaﬂuorophenyl (PFP) ligand that
emonstrated mixed-mode RP/SCX interactions, and it is believed
hat the silanols in the vicinity of the perﬂuorinated ligand act
s strongly acidic sites. The separations of peptides, phospho-
eptides, and sialylated glycopeptides were demonstrated. Alpert
154] reported that when a predominantly organic mobile phase
s used, IEX column can retain solutes through hydrophilic inter-
ction even if they have the same charge as the stationary phase,
nd termed this combination as electrostatic repulsion-hydrophilic
nteraction chromatography (ERLIC). By using this mixed-mode
eparation, phosphopeptides can be isolated selectively from a
ryptic digest. Yates [155,156] used a biphasic SCX/RP capillary col-
mn  that was ﬁrst packed with Zorbax Eclipse XDB C18 and then
ith Partisphere strong cation exchange (SCX) coupled with MS/MS
or proteomic analysis of peptides.
More applications have been reported in recently years using
tationary phases purposely designed to have multiple functional
roups to provide different interaction mechanism. Nogueira
t al. [157] reported a mixed-mode RP/WAX stationary phase
ased on N-(10-undecenoyl)-3-aminoquinuclidine selector, which
s covalently immobilized on thiol-modiﬁed silica particles bychange (RP/WAX) stationary phase utilized in Ref. [158].
radical addition reaction. The stationary phase has hydrophobic RP
domains through the alkyl chains and hydrophilic WAX  domains
through the cationic sites, which also enables repulsive ionic
interactions with positively charged functional groups, leading to
ion-exclusion phenomena. This mixed-mode phase was applied
to the separation and puriﬁcation.of the N- and C-terminally
protected tetrapeptide N-acetyl-Ile-Glu-Gly-Arg-p-nitroanilide
from its side products. Better selectivity and enhanced sample
loading capacity in comparison to RP-HPLC (gradient of ACN
containing TFA as ion-pairing agent) was demonstrated. The yield
was improved by a factor of about 15 higher compared to the
standard gradient elution RP puriﬁcation protocol.
Lämmerhofer et al. [158] introduced a RP/WAX mixed-mode
silica based phase devised for peptide separations. As shown in
Fig. 8 the stationary phase contains a hydrophobic alkyl strand
with polar embedded groups (thioether and amide functionalities)
and a terminal weak anion-exchange-type quinuclidine moiety. It
demonstrated that depending on the solute properties and mobile
phase conditions, the column can be used in RP (neutral com-
pounds), AEX (acidic compounds), ion-exclusion mode (cationic
solutes), HILIC (polar compounds), and HIC (e.g., hydrophobic pep-
tides) modes.
3.8. Proteins
In this section, we  review the recent advances of the MMC  in
the therapeutic protein and related area. Readers are encouraged
to read earlier reviews for ligands for mixed-mode protein chro-
matography [14], and its applications to biopolymer [159].
Protein aggregation can happen during biopharmaceutical man-
ufacturing processes, formulation processes, shipping and storage.
Aggregation may  cause side effects and reduce the efﬁcacy of the
products, and have the potential to induce undesirable immuno-
logical responses. Aggregation is a critical quality attribute of
therapeutic protein products. It is important to effectively remove,
monitor and control mAb  aggregates. Gao et al. [6] evaluated anti-
body monomer separation from associated aggregates using three
mixed-mode resins, Capto adhere (CA) and two home-made resins
with benzylamine and butylamine as the functional ligands (named
BA and AB). It was  found that the removal efﬁciency was highly
dependent on the mass loading. With the sample load of 50 mg/ml
resin both Capto adhere and BA resins can signiﬁcantly reduce
the aggregate level from 20.5% to 2.6% and 2.4%, respectively. The
results indicate that both hydrophobic interaction and electrostatic
interaction are critical for the aggregate removal and that the coop-
eration of different molecular interactions is important for the
effective aggregates removal with mixed-mode resins.
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Misfolding and aggregation frequently occurs during production
f recombinant proteins. Misfolding species are made of the same
rotein and may  have similar electrostatic charges and hydropho-
icity, and therefore could be difﬁcult to be separated from the
ative species. The isoform separation of proteins by mixed-mode
hromatography has been reported [160]. Two GE mixed-mode
esins, anion-exchange Capto adhere and cation-exchange Capto
MC are applied to two model proteins, etanercept, which has
een shown to misfold and bovine serum albumin (BSA) that has
een shown to aggregate. The mixed-mode ligands have a chemical
tructure that provides different interaction modes, primarily elec-
rostatic and hydrophobic/aromatic for protein binding. Effective
eparation of the misfolded etanercept species and BSA oligomers
as been developed in this study using elution conditions that com-
ine pH change and NaCl or arginine at different concentrations.
The puriﬁcation of the recombinant allergen rBet v 1a was
nvestigated using a family of three mixed-mode sorbents, namely,
EA HyperCel (hexyl amine), PPA HyperCel (phenyl propyl amine)
nd MEP  HyperCel (mercapto ethyl pyridine) [161]. Because it
s difﬁcult to predict the protein binding and desorption condi-
ions of mixed-mode sorbents with multi-modal interactions, the
creening of sorbents was  carried out on a high throughput plat-
orm in a 96-well microplate combined with SELDI-MS. The results
howed the capture and 9-fold puriﬁcation of rBet v 1a in a single
hromatography step on HEA or PPA HyperCel sorbents without
he pre-treatment of the crude E. coli feedstock, saving the cost
nd time of an extra step often necessary prior to IEX (i.e. dilution
r diaﬁltration) or conventional HIC (addition of lyotropic salts).
Studies also show that proteins of lower stability may  exhibit
nfolding and aggregation during IEC and MMC  separations, as
hey can with hydrophobic interaction chromatography. This could
ead to decreased yield and product degradation. Gospodarek et al.
162] using hydrogen exchange mass spectrometry, investigated
he unfolding behavior of the model protein BSA on IEX and MMC
Capto TMMMC  and Capto TMAdhere) resin surfaces under differ-
nt solution conditions at 25 ◦C. The study suggested that adsorbed
SA unfolds at lower pH values and may  show aggregation, and it is
he cationic moieties, rather than the hydrophobic ligands, which
ause greater surface unfolding at low salt concentrations.
It is important to characterize therapeutic antibody heterogene-
ty due to the fact that structural heterogeneity often affects the
ioactivity and efﬁcacy of a drug. Heterogeneity of mAbs can come
rom post-translational modiﬁcations as well as inherent mod-
ﬁcations during manufacturing process and storage conditions.
odiﬁcations that result in structural heterogeneity include but
re not limited to incomplete disulﬁde bond formation, glycosyl-
tion, isomerization, C-terminal lysine processing, deamidation,
nd oxidation etc. [163,17]. Measuring oxidative variants can be
hallenging due to its similarities to the native antibody molecule
n size, charge, and hydrophobicity. Wong et al. developed size
xclusion − ultra performance liquid chromatography (SE-UPLC),
mploying a Waters Acquity BEH200 size exclusion column along
ith a mobile phase consisting of sodium acetate and sodium sul-
ate that separates IgG into aggregate, monomer, and fragment [17].
he mixed-mode retention behavior of SEC column was observed
hen use of a moderate salt concentration based on hydropho-
icity, resolved a Trp-oxidized IgG monomer pre-peak from the
onomer main peak. Method qualiﬁcation of the mixed mode UPLC
ethod showed good recovery for the spiked monomer pre-peak
nd Fab fragment. However, the recovery of spiked dimer was low.
his method is suitable for the determination of variant monomeric
gG species.Recently, Yang et al. employed a mixed-mode chromatography
sing a Sepax Zenix SEC-300 column to separate an IgG4 bispe-
iﬁc hybrid from the parental antibodies [3]. Comparing to other
vailable methods that mostly necessitate labeling or alteration of Biomedical Analysis 130 (2016) 19–34
the model IgG4 molecules, or rely on time-consuming immunoas-
says and mass spectrometry, the mixed-mode method not only
allow the analysis of the bispeciﬁc hybrids to study half molecule
exchange of in vitro as well as in vivo samples, but also allow the
isolation of hybrid antibodies from intact parental antibodies.
Porous polymer monolithic columns with gold nanoparticles
for the separation of proteins in RP-IEX mixed mode was  recently
reported [164]. It was  demonstrated the mixed mode character of
these monolithic stationary phases in the separations of proteins
that could be achieved in the same column using gradient elution
conditions typical of reverse phase (using gradient of acetonitrile
in water) and ion exchange chromatographic modes (applying
gradient of salt in water), respectively. The puriﬁcation of rabbit
polyclonal immunoglobulin G using mixed mode chromatography
SepFastTM MM AH-1 was recently reported [165]. A three-step pro-
cess involved two  mixed mode resins (HEA HyperCel and Capto
MMC)  and an anion exchange membrane polishing was recently
reported for the puriﬁcation of mAb  from CHO cell culture super-
natant [4].
4. Conclusion and perspectives
Mixed-mode chromatography provides unique selectivity espe-
cially for polar and charged analytes. The multiple interaction
mechanisms allow the users to adjust the mobile phase/eluent con-
ditions to promote certain interactions for certain analytes. MMC
has advanced from original “secondary interaction” to purposely
designed and controlled multi-mode interactions. The new gener-
ation of mixed-mode stationary phases is more robust and diverse.
The recent commercialization of mixed-mode stationary phases
greatly enhanced the applications of MMC.
MMC  has been successfully applied in pharmaceutics for
counter ion analysis, polar and/or charged APIs, impurities, for-
mulation excipients, and environmental and biological samples.
Mixed-mode sorbents, SPEs have been effectively applied in sam-
ple matrices cleanup and increasing LC–MS sensitivity. MMC  plays
an important role in peptide and protein analysis and puriﬁcation,
antibody aggregation and heterogeneity characterization.
MMC  can replace IEX in many applications and allow using
MS compatible mobile phases. MMC  is superior to RP for some
applications, but mostly for the analytes that are not retained and
separated well by the traditional RP columns. Although MMC  has
been applied in impurity proﬁling of pharmaceutical samples, it
is mainly for impurities that have diverse properties. MMC  is not
used as a primary tool replacing RP for assay and impurity method
in pharmaceutical industry yet for general applications. However,
it is highly desirable to have such a mixed-mode column that
not only separate inorganic ions polar and charged analytes and
organic molecules, but also provide the resolution and peak capac-
ity that comparable to RP columns to separate structurally similar
compounds.
While MMC  provides an increased number of tunable variables
that provides more ﬂexibility in method development and more
applications to a variety of analytes, it also complicates the method
development. Method development of MMC  is more time consum-
ing and less straight forward comparing to any of the individual
chromatography modes alone. Platform methods and protocols
are efﬁcient approaches to apply MMC  in pharmaceutical and bio-
pharmaceutical analysis. Further understanding of the separation
mechanisms of MMC  is necessary to help method development.We  thank Xuefei Sun of Thermo Fisher Scientiﬁc for helping edit
some of the references, Geoffrey Yeh and Sam Yang of Genentech
for reviewing the manuscript.
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